Rare Disorders NZ appalled by attitude within PHARMAC; calls for Chair’s removal

11 October 2023 - Rare Disorders New Zealand is calling on the Minister of Health to remove Steve Maharey as ...

Read more →

PHARMAC needs to work for patients, not itself

10 October 2023 - “The internal chaos and siege mentality at PHARMAC is exactly why the next Government needs to ...

Read more →

Calls to sack PHARMAC boss after 'sick, sneering' remarks

8 October 2023 - A top cancer specialist says PHARMAC chief executive Sarah Fitt should step down over “offensive” emails, ...

Read more →

ICER appoints Daniel Ollendorf as Chief Scientific Officer and Director of HTA Methods and Engagement

27 September 2023 - Academic leader in HTA to rejoin ICER in November 2023. ...

Read more →

ICER announces leadership transition

28 June 2023 - Founder and President Steve Pearson to transition to advisor role at beginning of 2024; long-time EVP ...

Read more →

PHARMAC announces new Deputy Medical Director Māori

19 April 2023 - PHARMAC has welcomed Dr Kiri Prentice (Ngāi Tūhoe and Ngāti Awa) to the newly established role ...

Read more →

CEO’s appointment to HTA Review Reference Committee

15 March 2023 - CEO of Medicines Australia, Elizabeth de Somer, has been appointed as the medicines industry representative on ...

Read more →

Member of Canada’s drug pricing regulator quits over ‘lack of support’ for medicine cost reforms

23 February 2023 - A member of the Patented Medicine Prices Review Board, Canada’s drug pricing regulator, has resigned over ...

Read more →

Thomas Kaiser becomes the new head of IQWiG

16 February 2023 - The current head of the IQWiG department for drug assessment succeeds Jürgen Windeler, who is retiring after ...

Read more →

Professor John Skerritt retirement

2 February 2023 - Today, Professor John Skerritt has announced his decision to retire from his position of Deputy Secretary ...

Read more →

New name for Department

1 July 2022 - The Department of Health is now called the Australian Government Department of Health and Aged Care.  ...

Read more →

The FDA’s Pazdur on accelerated approval, single-arm studies and his own future

4 June 2022 - When cancer drugs granted accelerated approval in the U.S. later turn out not to benefit patients, the ...

Read more →

EMA appoints Chief Medical Officer

1 June 2022 - Steffen Thirstrup has been appointed as Chief Medical Officer of the EMA.  ...

Read more →

Biden has confidence in the FDA and its commissioner, White House says

27 May 2022 - U.S. President Joe Biden has confidence in the U.S. FDA and its commissioner Robert Califf, White House ...

Read more →

FDA’s Califf shares priority list with agency staff

18 February 2022 - Combatting misinformation about science and responding to the ongoing COVID-19 pandemic are the top priorities for ...

Read more →